Hologic Given "Buy" Rating at BTIG Research (HOLX)

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Hologic Given "Buy" Rating at BTIG Research (HOLX)

http://www.tickerreport.com/banking-finance/496847/hologic-given-buy-rating-at-btig-research-holx/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN

Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Hologic Charts.

Hologic (NASDAQ:HOLX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Hologic Charts.

News

Hologic Announces Financial Results for Second Quarter of Fiscal 2024
Friday 3 May 2024 (2 days ago) • Business Wire

Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company
Tuesday 30 April 2024 (5 days ago) • Business Wire

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
Tuesday 2 April 2024 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
Wednesday 6 March 2024 (2 months ago) • Business Wire

More News Articles

AUD vs US Dollar

JP Morgan Chase

Verizon Communications

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions